(Q53558832)

15 May 2018

title

Limited feasibility of double transplant in multiple myeloma: results of a multicenter study on 153 patients aged <65 years. (English)

1 reference

15 May 2018

author name string

Alessandro Corso

1

1 reference

15 May 2018

Silvia Mangiacavalli

2

1 reference

15 May 2018

Luciana Barbarano

3

1 reference

15 May 2018

Emilio Paolo Alessandrino

4

1 reference

15 May 2018

Roberto Cairoli

5

1 reference

15 May 2018

Enrica Morra

6

1 reference

15 May 2018

Mario Lazzarino

7

1 reference

15 May 2018

HOST Group

8

1 reference

15 May 2018

language of work or name

English

0 references

publication date

1 June 2007

1 reference

15 May 2018

published in

Cancer

1 reference

15 May 2018

volume

109

1 reference

15 May 2018

page(s)

2273-2278

1 reference

15 May 2018

issue

11

1 reference

15 May 2018

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22660

7 January 2021

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22660

7 January 2021

High-dose therapy and autologous blood stem-cell transplantation compared with conventional treatment in myeloma patients aged 55 to 65 years: long-term results of a randomized control trial from the Group Myelome-Autogreffe

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22660

7 January 2021

Standard chemotherapy compared with high-dose chemoradiotherapy for multiple myeloma: final results of phase III US Intergroup Trial S9321.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22660

7 January 2021

High-dose therapy intensification compared with continued standard chemotherapy in multiple myeloma patients responding to the initial chemotherapy: long-term results from a prospective randomized trial from the Spanish cooperative group PETHEMA.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22660

7 January 2021

Impact of complete remission with intensive therapy in patients with responsive multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22660

7 January 2021

Long-term outcome results of the first tandem autotransplant trial for multiple myeloma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22660

7 January 2021

Single versus double autologous stem-cell transplantation for multiple myeloma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22660

7 January 2021

High-dose therapy in multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22660

7 January 2021

Multiple myeloma, 2004--one or two transplants?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22660

7 January 2021

https://api.crossref.org/works/10.1002%2FCNCR.22660

1 reference

7 January 2021

Treatment of multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22660

7 January 2021

Identifiers

DOI

10.1002/CNCR.22660

1 reference

15 May 2018

PubMed ID

17440982

1 reference

15 May 2018